Loading insider details...
Latest Form 4 (Feb 27, 2026): Grant/Award of 1,300,000 PRME shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 27, 2026 | Prime Medicine, Inc. (PRME) | Grant/Award | 1,300,000 | n/a |
| Aug 6, 2025 | Prime Medicine, Inc. (PRME) | Disposition to Issuer | 850,000 | n/a |
| May 22, 2025 | Prime Medicine, Inc. (PRME) | Purchase | 125,000 | $147.2K |
| May 19, 2025 | Prime Medicine, Inc. (PRME) | Grant/Award | 2,000,000 | n/a |
| May 12, 2025 | Prime Medicine, Inc. (PRME) | Grant/Award | 75,000 | n/a |
| Mar 4, 2025 | Prime Medicine, Inc. (PRME) | Grant/Award | 275,000 | n/a |
| Dec 9, 2024 | Prime Medicine, Inc. (PRME) | Grant/Award | 75,000 | n/a |
| May 21, 2024 | Prime Medicine, Inc. (PRME) | Grant/Award | 100,000 | n/a |
| Jan 19, 2024 | Prime Medicine, Inc. (PRME) | Grant/Award | 600,000 | n/a |
| Jan 30, 2023 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 90,000 | n/a |